{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "23",
                "@timestamp": "2021-02-23T16:27:55.000055-05:00",
                "@year": "2021",
                "@month": "02"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2019",
                "@month": "01"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding-addon-generated-timestamp": "2019-01-10T22:20:09.085Z",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/car"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "address-part": "2 Wanglang Rd",
                            "postal-code": "10700",
                            "@afid": "60199575",
                            "@country": "tha",
                            "city": "Bangkoknoi, Bangkok",
                            "organization": [
                                {"$": "Division of Rheumatology"},
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Siriraj Hospital"},
                                {"$": "Mahidol University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60199575",
                                    "@dptid": "125758157"
                                },
                                {"@afid": "60012718"}
                            ],
                            "@dptid": "125758157"
                        },
                        "author": [
                            {
                                "ce:given-name": "Praveena",
                                "preferred-name": {
                                    "ce:given-name": "Praveena",
                                    "ce:initials": "P.",
                                    "ce:surname": "Chiowchanwisawakit",
                                    "ce:indexed-name": "Chiowchanwisawakit P."
                                },
                                "@seq": "1",
                                "ce:initials": "P.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Chiowchanwisawakit",
                                "@auid": "12645013800",
                                "ce:indexed-name": "Chiowchanwisawakit P."
                            },
                            {
                                "ce:given-name": "Wanruchada",
                                "preferred-name": {
                                    "ce:given-name": "Wanruchada",
                                    "ce:initials": "W.",
                                    "ce:surname": "Katchamart",
                                    "ce:indexed-name": "Katchamart W."
                                },
                                "@seq": "2",
                                "ce:initials": "W.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:degrees": "MD",
                                "ce:surname": "Katchamart",
                                "@auid": "26654177400",
                                "ce:indexed-name": "Katchamart W."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "organization": [
                                {"$": "Division of Rheumatology"},
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "113019942"
                            },
                            "@dptid": "113019942"
                        },
                        "author": [{
                            "ce:given-name": "Manathip",
                            "preferred-name": {
                                "ce:given-name": "Manathip",
                                "ce:initials": "M.",
                                "ce:surname": "Osiri",
                                "ce:indexed-name": "Osiri M."
                            },
                            "@seq": "3",
                            "ce:initials": "M.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD, MSc",
                            "ce:surname": "Osiri",
                            "@auid": "6701738522",
                            "ce:indexed-name": "Osiri M."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "118691477",
                            "@country": "tha",
                            "organization": [
                                {"$": "Division of Rheumatology"},
                                {"$": "Department of Internal Medicine"},
                                {"$": "Phramongkutklao Hospital and College of Medicine"}
                            ],
                            "affiliation-id": {
                                "@afid": "118691477",
                                "@dptid": "121926824"
                            },
                            "@dptid": "121926824"
                        },
                        "author": [{
                            "ce:given-name": "Pongthorn",
                            "preferred-name": {
                                "ce:given-name": "Pongthorn",
                                "ce:initials": "P.",
                                "ce:surname": "Narongroeknawin",
                                "ce:indexed-name": "Narongroeknawin P."
                            },
                            "@seq": "4",
                            "ce:initials": "P.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Narongroeknawin",
                            "@auid": "35099091000",
                            "ce:indexed-name": "Narongroeknawin P."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60199578",
                            "@country": "tha",
                            "organization": [
                                {"$": "Division of Allergy Immunology and Rheumatology"},
                                {"$": "Department of Internal Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Ramathibodi Hospital"},
                                {"$": "Mahidol University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60199578",
                                    "@dptid": "125771209"
                                },
                                {"@afid": "60012718"}
                            ],
                            "@dptid": "125771209"
                        },
                        "author": [{
                            "ce:given-name": "Parawee",
                            "preferred-name": {
                                "ce:given-name": "Parawee",
                                "ce:initials": "P.",
                                "ce:surname": "Chevaisrakul",
                                "ce:indexed-name": "Chevaisrakul P."
                            },
                            "@seq": "5",
                            "ce:initials": "P.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Chevaisrakul",
                            "@auid": "57191876780",
                            "ce:indexed-name": "Chevaisrakul P."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60005255",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Rheumatology Unit"},
                                {"$": "Department of Medicine"},
                                {"$": "Rajavithi Hospital"},
                                {"$": "Ministry of Public Health"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60005255",
                                    "@dptid": "103306446"
                                },
                                {"@afid": "60015728"}
                            ],
                            "@dptid": "103306446"
                        },
                        "author": [{
                            "ce:given-name": "Tasanee",
                            "preferred-name": {
                                "ce:given-name": "Tasanee",
                                "ce:initials": "T.",
                                "ce:surname": "Kitumnuaypong",
                                "ce:indexed-name": "Kitumnuaypong T."
                            },
                            "@seq": "6",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Kitumnuaypong",
                            "@auid": "7801652692",
                            "ce:indexed-name": "Kitumnuaypong T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60025527",
                            "@country": "tha",
                            "city": "Songkla",
                            "organization": [
                                {"$": "Division of Rheumatology"},
                                {"$": "Department of Internal Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Prince of Songkla University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60025527",
                                    "@dptid": "122437713"
                                },
                                {"@afid": "60006314"}
                            ],
                            "@dptid": "122437713"
                        },
                        "author": [{
                            "ce:given-name": "Boonjing",
                            "preferred-name": {
                                "ce:given-name": "Boonjing",
                                "ce:initials": "B.",
                                "ce:surname": "Siripaitoon",
                                "ce:indexed-name": "Siripaitoon B."
                            },
                            "@seq": "7",
                            "ce:initials": "B.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Siripaitoon",
                            "@auid": "6506081502",
                            "ce:indexed-name": "Siripaitoon B."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60000881",
                            "@country": "tha",
                            "city": "Chiang Mai",
                            "organization": [
                                {"$": "Division of Rheumatology"},
                                {"$": "Department of Internal Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chiang Mai University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60000881",
                                "@dptid": "103084152"
                            },
                            "@dptid": "103084152"
                        },
                        "author": [{
                            "ce:given-name": "Worawit",
                            "preferred-name": {
                                "ce:given-name": "Worawit",
                                "ce:initials": "W.",
                                "ce:surname": "Louthrenoo",
                                "ce:indexed-name": "Louthrenoo W."
                            },
                            "@seq": "8",
                            "ce:initials": "W.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Louthrenoo",
                            "@auid": "7004628644",
                            "ce:indexed-name": "Louthrenoo W."
                        }]
                    }
                ],
                "citation-title": "Effectiveness and Drug Survival of Anti-Tumor Necrosis Factor Therapies in Patients with Spondyloarthritis: Analysis from the Thai Rheumatic Disease Prior Authorization Registry",
                "abstracts": "Â© 2018 Wolters Kluwer Health, Inc. All rights reserved.Objective This study aimed to evaluate the long-term effectiveness and safety of the first anti-tumor necrosis factor therapy (TNFi) and to identify the associated factors of drug discontinuation in patients with spondyloarthritis. Methods This was a medical records review study. Patients with spondyloarthritis who were prescribed the first TNFi between December 2009 and October 2014 in the Rheumatic Disease Prior Authorization registry were enrolled. Baseline clinical data were retrieved. The Cox proportional hazards model was used to identify factors associated with discontinuation of drugs. Results Among 138 patients, 97 had ankylosing spondylitis (AS), and 41 had psoriatic arthritis (PsA). The effectiveness of TNFi in AS and PsA was 55% to 59% at 4 months and 75% to 96% at 3 years, as measured by a 50% decrease in the Bath Ankylosing Spondylitis Disease Activity Index from baseline. For PsA with peripheral arthritis, improvement of the joint count by 50% was observed in 61.8% of patients at 4 months and 100% at 3 years. Survival from TNFi was 63% for AS and 56% for PsA at 3 years. For AS, the factors associated with good response leading to discontinuation of TNFi were baseline patient global assessment 3 to 6/10 (hazard ratio [HR], 6.3) and the use of leflunomide (HR, 6.0) and infliximab (HR, 4.8). A good response (38.5%) was the most common cause of discontinuation of the first TNFi, followed by toxicity (28.2%), nonadherence (20.5%), and lack of effectiveness (12.8%). Conclusions Ankylosing spondylitis and PsA responded well to TNFi during the 3-year follow-up. The retention rate was approximately 60% for AS and PsA. A good response to the first TNFi was the most common reason for discontinuation.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "address-part": "2 Wanglang Rd",
                        "postal-code": "10700",
                        "@country": "tha",
                        "city": "Bangkoknoi, Bangkok",
                        "organization": [
                            {"$": "Division of Rheumatology"},
                            {"$": "Department of Medicine"},
                            {"$": "Faculty of Medicine"},
                            {"$": "Siriraj Hospital"},
                            {"$": "Mahidol University"}
                        ]
                    },
                    "person": {
                        "ce:given-name": "Praveena",
                        "ce:initials": "P.",
                        "ce:degrees": "MD",
                        "ce:surname": "Chiowchanwisawakit",
                        "ce:indexed-name": "Chiowchanwisawakit P."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "anti-TNF agent",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "AS",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "PsA",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "spondyloarthritis",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "survival",
                            "@xml:lang": "eng"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "http://journals.lww.com/jclinrheum/pages/default.aspx",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Journal of Clinical Rheumatology",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "25",
                            "@issue": "1"
                        },
                        "pagerange": {
                            "@first": "9",
                            "@last": "15"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "Journal of Clinical Rheumatology",
                    "publicationdate": {
                        "month": "01",
                        "year": "2019",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "1 January 2019"
                        },
                        "day": "01"
                    },
                    "codencode": "JCRHF",
                    "sourcetitle-abbrev": "J. Clin. Rheumatol.",
                    "@country": "usa",
                    "issn": [
                        {
                            "$": "15367355",
                            "@type": "electronic"
                        },
                        {
                            "$": "10761608",
                            "@type": "print"
                        }
                    ],
                    "publicationyear": {"@first": "2019"},
                    "publisher": {
                        "publishername": "Lippincott Williams and Wilkins",
                        "ce:e-address": {
                            "$": "kathiest.clai@apta.org",
                            "@type": "email"
                        }
                    },
                    "@srcid": "19236"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "31",
                                    "classification-description": "Arthritis and Rheumatism"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "38",
                                    "classification-description": "Adverse Reactions Titles"
                                },
                                {
                                    "classification-code": "6",
                                    "classification-description": "Internal Medicine"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": "2745"
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MEDI"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": [
                        {
                            "@source": "esbd",
                            "chemical": [
                                {
                                    "cas-registry-number": [
                                        {"$": "185243-69-0"},
                                        {"$": "200013-86-1"},
                                        {"$": "2055118-96-0"}
                                    ],
                                    "chemical-name": "etanercept"
                                },
                                {
                                    "cas-registry-number": "170277-31-3",
                                    "chemical-name": "infliximab"
                                },
                                {
                                    "cas-registry-number": "75706-12-6",
                                    "chemical-name": "leflunomide"
                                },
                                {
                                    "cas-registry-number": [
                                        {"$": "15475-56-6"},
                                        {"$": "59-05-2"},
                                        {"$": "7413-34-5"}
                                    ],
                                    "chemical-name": "methotrexate"
                                },
                                {
                                    "cas-registry-number": "599-79-1",
                                    "chemical-name": "salazosulfapyridine"
                                }
                            ]
                        },
                        {
                            "@source": "nlm",
                            "chemical": [
                                {"chemical-name": "Antirheumatic Agents"},
                                {"chemical-name": "Etanercept"},
                                {"chemical-name": "Infliximab"},
                                {"chemical-name": "Tumor Necrosis Factor-alpha"}
                            ]
                        }
                    ]}
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2019 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "external-source": "In-Process",
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "MEDL"},
                    {"$": "MOSYEA"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "14",
                    "@timestamp": "BST 11:20:26",
                    "@year": "2019",
                    "@month": "01"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "625823659",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "625621802",
                            "@idtype": "associatedPUI"
                        },
                        {
                            "$": "915001296",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20190017509",
                            "@idtype": "EMBASE"
                        },
                        {
                            "$": "29517554",
                            "@idtype": "MEDL"
                        },
                        {
                            "$": "2019002296",
                            "@idtype": "MOSYEA"
                        },
                        {
                            "$": "20190044605",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20190067931",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "85058911924",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85058911924",
                            "@idtype": "SGR"
                        },
                        {
                            "$": "625621802",
                            "@idtype": "PUIsecondary"
                        },
                        {
                            "$": "76914699",
                            "@idtype": "OSIN"
                        }
                    ],
                    "ce:doi": "10.1097/RHU.0000000000000741"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "38",
                "reference": [
                    {
                        "ref-fulltext": "Van der Heijde D Ramiro S Landewe R. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017; 76: 978-991.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85011039422",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "76"},
                                "pagerange": {
                                    "@first": "978",
                                    "@last": "991"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Van Der Heijde",
                                    "ce:indexed-name": "Van Der Heijde D."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Ramiro",
                                    "ce:indexed-name": "Ramiro S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Landewe",
                                    "ce:indexed-name": "Landewe R."
                                }
                            ]},
                            "ref-sourcetitle": "Ann Rheum Dis"
                        }
                    },
                    {
                        "ref-fulltext": "Coates LC Kavanaugh A Mease PJ. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 treatment recommendations for psoriatic arthritis. Arthritis Rheumatol. 2016; 68: 1060-1071.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 treatment recommendations for psoriatic arthritis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84959912573",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "68"},
                                "pagerange": {
                                    "@first": "1060",
                                    "@last": "1071"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Coates",
                                    "ce:indexed-name": "Coates L.C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Kavanaugh",
                                    "ce:indexed-name": "Kavanaugh A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Mease",
                                    "ce:indexed-name": "Mease J."
                                }
                            ]},
                            "ref-sourcetitle": "Arthritis Rheumatol"
                        }
                    },
                    {
                        "ref-fulltext": "Thai Rheumatism Association. Guideline for anti-TNF therapy in ankylosing spondylitis and psoriatic arthritis 2010. Available at: http://www.thairheumatology.org/download/guideline-biolo-gic-therapy.pdf. Accessed April 2, 2016.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.thairheumatology.org/download/guideline_biolo_gic_therapy.pdf",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85059562224",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Accessed April 2",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "Thai Rheumatism Association",
                                "ce:indexed-name": "Thai Rheumatism Association"
                            }},
                            "ref-sourcetitle": "Guideline for Anti-TNF Therapy in Ankylosing Spondylitis and Psoriatic Arthritis 2010"
                        }
                    },
                    {
                        "ref-fulltext": "Chen J Veras MM Liu C. Methotrexate for ankylosing spondylitis. Cochrane Database Syst Rev. 2013; 2: CD004524.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Methotrexate for ankylosing spondylitis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "39049174015",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "2"},
                                "pagerange": {"@first": "CD004524"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Chen",
                                    "ce:indexed-name": "Chen J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Veras",
                                    "ce:indexed-name": "Veras M.M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Liu",
                                    "ce:indexed-name": "Liu C."
                                }
                            ]},
                            "ref-sourcetitle": "Cochrane Database Syst Rev"
                        }
                    },
                    {
                        "ref-fulltext": "Chen J Lin S Liu C. Sulfasalazine for ankylosing spondylitis. Cochrane Database Syst Rev. 2014; 11: CD004800.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Sulfasalazine for ankylosing spondylitis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84964312947",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {"@first": "CD004800"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Chen",
                                    "ce:indexed-name": "Chen J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Lin",
                                    "ce:indexed-name": "Lin S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Liu",
                                    "ce:indexed-name": "Liu C."
                                }
                            ]},
                            "ref-sourcetitle": "Cochrane Database Syst Rev"
                        }
                    },
                    {
                        "ref-fulltext": "van Denderen JC van der Paardt M Nurmohamed MT. Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis. Ann Rheum Dis. 2005; 64: 1761-1764.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "23844527232",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "64"},
                                "pagerange": {
                                    "@first": "1761",
                                    "@last": "1764"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Van Denderen",
                                    "ce:indexed-name": "Van Denderen J.C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Van Der Paardt",
                                    "ce:indexed-name": "Van Der Paardt M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.T.",
                                    "@_fa": "true",
                                    "ce:surname": "Nurmohamed",
                                    "ce:indexed-name": "Nurmohamed M.T."
                                }
                            ]},
                            "ref-sourcetitle": "Ann Rheum Dis"
                        }
                    },
                    {
                        "ref-fulltext": "Haibel H Rudwaleit M Braun J. Six months open label trial of leflunomide in active ankylosing spondylitis. Ann Rheum Dis. 2005; 64: 124-126.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Six months open label trial of leflunomide in active ankylosing spondylitis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "11344271068",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "64"},
                                "pagerange": {
                                    "@first": "124",
                                    "@last": "126"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Haibel",
                                    "ce:indexed-name": "Haibel H."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Rudwaleit",
                                    "ce:indexed-name": "Rudwaleit M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Braun",
                                    "ce:indexed-name": "Braun J."
                                }
                            ]},
                            "ref-sourcetitle": "Ann Rheum Dis"
                        }
                    },
                    {
                        "ref-fulltext": "Can M Aydin SZ Nigdelioglu A. Conventional DMARD therapy (methotrexate-sulphasalazine) may decrease the requirement of biologics in routine practice of ankylosing spondylitis patients: a real-life experience. Int J Rheum Dis. 2012; 15: 526-530.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Conventional DMARD therapy (methotrexate-sulphasalazine) may decrease the requirement of biologics in routine practice of ankylosing spondylitis patients: A real-life experience"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84871408440",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "15"},
                                "pagerange": {
                                    "@first": "526",
                                    "@last": "530"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Can",
                                    "ce:indexed-name": "Can M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.Z.",
                                    "@_fa": "true",
                                    "ce:surname": "Aydin",
                                    "ce:indexed-name": "Aydin S.Z."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Nigdelioglu",
                                    "ce:indexed-name": "Nigdelioglu A."
                                }
                            ]},
                            "ref-sourcetitle": "Int J Rheum Dis"
                        }
                    },
                    {
                        "ref-fulltext": "Lie E Kristensen LE Forsblad-d'Elia H. The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study. Ann Rheum Dis. 2015; 74: 970-978.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: Results from a nationwide prospective study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84934939391",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "74"},
                                "pagerange": {
                                    "@first": "970",
                                    "@last": "978"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Lie",
                                    "ce:indexed-name": "Lie E."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Kristensen",
                                    "ce:indexed-name": "Kristensen L.E."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Forsblad-D'Elia",
                                    "ce:indexed-name": "Forsblad-D'Elia H."
                                }
                            ]},
                            "ref-sourcetitle": "Ann Rheum Dis"
                        }
                    },
                    {
                        "ref-fulltext": "Marzo-Ortega H McGonagle D Jarrett S. Infliximab in combination with methotrexate in active ankylosing spondylitis: a clinical and imaging study. Ann Rheum Dis. 2005; 64: 1568-1575.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Infliximab in combination with methotrexate in active ankylosing spondylitis: A clinical and imaging study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "22144494850",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "64"},
                                "pagerange": {
                                    "@first": "1568",
                                    "@last": "1575"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Marzo-Ortega",
                                    "ce:indexed-name": "Marzo-Ortega H."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "McGonagle",
                                    "ce:indexed-name": "McGonagle D."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Jarrett",
                                    "ce:indexed-name": "Jarrett S."
                                }
                            ]},
                            "ref-sourcetitle": "Ann Rheum Dis"
                        }
                    },
                    {
                        "ref-fulltext": "van der Linden S Valkenburg HA Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984; 27: 361-368.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1984"},
                            "ref-title": {"ref-titletext": "Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0021272107",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "27"},
                                "pagerange": {
                                    "@first": "361",
                                    "@last": "368"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Van Der Linden",
                                    "ce:indexed-name": "Van Der Linden S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "H.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Valkenburg",
                                    "ce:indexed-name": "Valkenburg H.A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Cats",
                                    "ce:indexed-name": "Cats A."
                                }
                            ]},
                            "ref-sourcetitle": "Arthritis Rheum"
                        }
                    },
                    {
                        "ref-fulltext": "Moll JM Wright V. Psoriatic arthritis. Semin Arthritis Rheum. 1973; 3: 55-78.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1973"},
                            "ref-title": {"ref-titletext": "Psoriatic arthritis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0015799817",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "3"},
                                "pagerange": {
                                    "@first": "55",
                                    "@last": "78"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Moll",
                                    "ce:indexed-name": "Moll J.M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "V.",
                                    "@_fa": "true",
                                    "ce:surname": "Wright",
                                    "ce:indexed-name": "Wright V."
                                }
                            ]},
                            "ref-sourcetitle": "Semin Arthritis Rheum"
                        }
                    },
                    {
                        "ref-fulltext": "Dougados M van der Linden S Juhlin R. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991; 34: 1218-1227.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1991"},
                            "ref-title": {"ref-titletext": "The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0026003027",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "34"},
                                "pagerange": {
                                    "@first": "1218",
                                    "@last": "1227"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Dougados",
                                    "ce:indexed-name": "Dougados M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Van Der Linden",
                                    "ce:indexed-name": "Van Der Linden S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Juhlin",
                                    "ce:indexed-name": "Juhlin R."
                                }
                            ]},
                            "ref-sourcetitle": "Arthritis Rheum"
                        }
                    },
                    {
                        "ref-fulltext": "Amor B Dougados M Mijiyawa M. Criteria of the classification of spondylarthropathies [in French]. Rev Rhum Mal Osteoartic. 1990; 57: 85-89.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1990"},
                            "ref-title": {"ref-titletext": "Criteria of the classification of spondylarthropathies [in French]"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0025377351",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "57"},
                                "pagerange": {
                                    "@first": "85",
                                    "@last": "89"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Amor",
                                    "ce:indexed-name": "Amor B."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Dougados",
                                    "ce:indexed-name": "Dougados M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Mijiyawa",
                                    "ce:indexed-name": "Mijiyawa M."
                                }
                            ]},
                            "ref-sourcetitle": "Rev Rhum Mal Osteoartic"
                        }
                    },
                    {
                        "ref-fulltext": "Davis JC Jr van Der Heijde D Braun J. Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial. Arthritis Rheum. 2003; 48: 3230-3236.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: A randomized, controlled trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0242411795",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "48"},
                                "pagerange": {
                                    "@first": "3230",
                                    "@last": "3236"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Davis",
                                    "ce:suffix": "Jr.",
                                    "ce:indexed-name": "Davis J.C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Van Der Heijde",
                                    "ce:indexed-name": "Van Der Heijde D."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Braun",
                                    "ce:indexed-name": "Braun J."
                                }
                            ]},
                            "ref-sourcetitle": "Arthritis Rheum"
                        }
                    },
                    {
                        "ref-fulltext": "van der Heijde D Dijkmans B Geusens P. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT). Arthritis Rheum. 2005; 52: 582-591.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Efficacy and safety of infliximab in patients with ankylosing spondylitis: Results of a randomized, placebo-controlled trial (ASSERT)"},
                            "refd-itemidlist": {"itemid": {
                                "$": "13444253765",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "52"},
                                "pagerange": {
                                    "@first": "582",
                                    "@last": "591"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Van Der Heijde",
                                    "ce:indexed-name": "Van Der Heijde D."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Dijkmans",
                                    "ce:indexed-name": "Dijkmans B."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Geusens",
                                    "ce:indexed-name": "Geusens P."
                                }
                            ]},
                            "ref-sourcetitle": "Arthritis Rheum"
                        }
                    },
                    {
                        "ref-fulltext": "van der Heijde D Kivitz A Schiff MH. Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2006; 54: 2136-2146.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double-blind, placebo-controlled trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33745894976",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "54"},
                                "pagerange": {
                                    "@first": "2136",
                                    "@last": "2146"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Van Der Heijde",
                                    "ce:indexed-name": "Van Der Heijde D."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Kivitz",
                                    "ce:indexed-name": "Kivitz A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Schiff",
                                    "ce:indexed-name": "Schiff M.H."
                                }
                            ]},
                            "ref-sourcetitle": "Arthritis Rheum"
                        }
                    },
                    {
                        "ref-fulltext": "Inman RD Davis JC Jr Heijde D. Efficacy and safety of golimumab in patients with ankylosing spondylitis: results of a randomized, double-blind, placebo-controlled, phase III trial. Arthritis Rheum. 2008; 58: 3402-3412.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Efficacy and safety of golimumab in patients with ankylosing spondylitis: Results of a randomized, double-blind, placebo-controlled, phase III trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "55849108826",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "58"},
                                "pagerange": {
                                    "@first": "3402",
                                    "@last": "3412"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Inman",
                                    "ce:indexed-name": "Inman R.D."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Davis",
                                    "ce:suffix": "Jr.",
                                    "ce:indexed-name": "Davis J.C."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Heijde",
                                    "ce:indexed-name": "Heijde D."
                                }
                            ]},
                            "ref-sourcetitle": "Arthritis Rheum"
                        }
                    },
                    {
                        "ref-fulltext": "Landewe R Braun J Deodhar A. Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled phase 3 study. Ann Rheum Dis. 2014; 73: 39-47.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled phase 3 study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84889654076",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "73"},
                                "pagerange": {
                                    "@first": "39",
                                    "@last": "47"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Landewe",
                                    "ce:indexed-name": "Landewe R."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Braun",
                                    "ce:indexed-name": "Braun J."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Deodhar",
                                    "ce:indexed-name": "Deodhar A."
                                }
                            ]},
                            "ref-sourcetitle": "Ann Rheum Dis"
                        }
                    },
                    {
                        "ref-fulltext": "Mease PJ Kivitz AJ Burch FX. Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression. Arthritis Rheum. 2004; 50: 2264-2272.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2004"},
                            "ref-title": {"ref-titletext": "Etanercept treatment of psoriatic arthritis: Safety, efficacy, and effect on disease progression"},
                            "refd-itemidlist": {"itemid": {
                                "$": "3042649266",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "50"},
                                "pagerange": {
                                    "@first": "2264",
                                    "@last": "2272"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Mease",
                                    "ce:indexed-name": "Mease J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Kivitz",
                                    "ce:indexed-name": "Kivitz A.J."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "F.X.",
                                    "@_fa": "true",
                                    "ce:surname": "Burch",
                                    "ce:indexed-name": "Burch F.X."
                                }
                            ]},
                            "ref-sourcetitle": "Arthritis Rheum"
                        }
                    },
                    {
                        "ref-fulltext": "Antoni C Krueger GG de Vlam K. Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis. 2005; 64: 1150-1157.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Infliximab improves signs and symptoms of psoriatic arthritis: Results of the IMPACT 2 trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "19044382942",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "64"},
                                "pagerange": {
                                    "@first": "1150",
                                    "@last": "1157"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Antoni",
                                    "ce:indexed-name": "Antoni C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "G.G.",
                                    "@_fa": "true",
                                    "ce:surname": "Krueger",
                                    "ce:indexed-name": "Krueger G.G."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "De Vlam",
                                    "ce:indexed-name": "De Vlam K."
                                }
                            ]},
                            "ref-sourcetitle": "Ann Rheum Dis"
                        }
                    },
                    {
                        "ref-fulltext": "Mease PJ Gladman DD Ritchlin CT. Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial. Arthritis Rheum. 2005; 52: 3279-3289.",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double-blind, randomized, placebo-controlled trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "26844432745",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "52"},
                                "pagerange": {
                                    "@first": "3279",
                                    "@last": "3289"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Mease",
                                    "ce:indexed-name": "Mease J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Gladman",
                                    "ce:indexed-name": "Gladman D.D."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C.T.",
                                    "@_fa": "true",
                                    "ce:surname": "Ritchlin",
                                    "ce:indexed-name": "Ritchlin C.T."
                                }
                            ]},
                            "ref-sourcetitle": "Arthritis Rheum"
                        }
                    },
                    {
                        "ref-fulltext": "Kavanaugh A McInnes I Mease P. Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: twenty-four-week efficacy and safety results of a randomized, placebo-controlled study. Arthritis Rheum. 2009; 60: 976-986.",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "65249137637",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "60"},
                                "pagerange": {
                                    "@first": "976",
                                    "@last": "986"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Kavanaugh",
                                    "ce:indexed-name": "Kavanaugh A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "I.",
                                    "@_fa": "true",
                                    "ce:surname": "McInnes",
                                    "ce:indexed-name": "McInnes I."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Mease",
                                    "ce:indexed-name": "Mease P."
                                }
                            ]},
                            "ref-sourcetitle": "Arthritis Rheum"
                        }
                    },
                    {
                        "ref-fulltext": "Mease PJ Fleischmann R Deodhar AA. Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a phase 3 double-blind randomised placebo-controlled study (RAPID-PsA). Ann Rheum Dis. 2014; 73: 48-55.",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a phase 3 double-blind randomised placebo-controlled study (RAPID-PsA)"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84889668023",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "73"},
                                "pagerange": {
                                    "@first": "48",
                                    "@last": "55"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Mease",
                                    "ce:indexed-name": "Mease P.J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Fleischmann",
                                    "ce:indexed-name": "Fleischmann R."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Deodhar",
                                    "ce:indexed-name": "Deodhar A.A."
                                }
                            ]},
                            "ref-sourcetitle": "Ann Rheum Dis"
                        }
                    },
                    {
                        "ref-fulltext": "Baraliakos X Haibel H Fritz C. Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years. Arthritis Res Ther. 2013; 15: R67.",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Long-term outcome of patients with active ankylosing spondylitis with etanercept-sustained efficacy and safety after seven years"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84879071427",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "15"},
                                "pagerange": {"@first": "R67"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "X.",
                                    "@_fa": "true",
                                    "ce:surname": "Baraliakos",
                                    "ce:indexed-name": "Baraliakos X."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Haibel",
                                    "ce:indexed-name": "Haibel H."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Fritz",
                                    "ce:indexed-name": "Fritz C."
                                }
                            ]},
                            "ref-sourcetitle": "Arthritis Res Ther"
                        }
                    },
                    {
                        "ref-fulltext": "Kavanaugh A McInnes IB Krueger GG. Patient-reported outcomes and the association with clinical response in patients with active psoriatic arthritis treated with golimumab: findings through 2 years of a phase III, multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Care Res (Hoboken). 2013; 65: 1666-1673.",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Patient-reported outcomes and the association with clinical response in patients with active psoriatic arthritis treated with golimumab: Findings through 2 years of a phase III, multicenter, randomized, double-blind, placebo-controlled trial"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84885013758",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "65"},
                                "pagerange": {
                                    "@first": "1666",
                                    "@last": "1673"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Kavanaugh",
                                    "ce:indexed-name": "Kavanaugh A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "I.B.",
                                    "@_fa": "true",
                                    "ce:surname": "McInnes",
                                    "ce:indexed-name": "McInnes I.B."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "G.G.",
                                    "@_fa": "true",
                                    "ce:surname": "Krueger",
                                    "ce:indexed-name": "Krueger G.G."
                                }
                            ]},
                            "ref-sourcetitle": "Arthritis Care Res (Hoboken)"
                        }
                    },
                    {
                        "ref-fulltext": "van der Heijde D Breban M Halter D. Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab. Rheumatology (Oxford). 2015; 54: 1210-1219.",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84936871214",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "54"},
                                "pagerange": {
                                    "@first": "1210",
                                    "@last": "1219"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Van Der Heijde",
                                    "ce:indexed-name": "Van Der Heijde D."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Breban",
                                    "ce:indexed-name": "Breban M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Halter",
                                    "ce:indexed-name": "Halter D."
                                }
                            ]},
                            "ref-sourcetitle": "Rheumatology (Oxford)"
                        }
                    },
                    {
                        "ref-fulltext": "Saad AA Ashcroft DM Watson KD. Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register. Arthritis Res Ther. 2009; 11: R52.",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: Observational study from the British Society of Rheumatology Biologics Register"},
                            "refd-itemidlist": {"itemid": {
                                "$": "65449189497",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {"@first": "R52"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Saad",
                                    "ce:indexed-name": "Saad A.A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Ashcroft",
                                    "ce:indexed-name": "Ashcroft D.M."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Watson",
                                    "ce:indexed-name": "Watson K.D."
                                }
                            ]},
                            "ref-sourcetitle": "Arthritis Res Ther"
                        }
                    },
                    {
                        "ref-fulltext": "Pavelka K Forejtova S Stolfa J. Anti-TNF therapy of ankylosing spondylitis in clinical practice. Results from the Czech national registry ATTRA. Clin Exp Rheumatol. 2009; 27: 958-963.",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Anti-TNF therapy of ankylosing spondylitis in clinical practice. Results from the Czech national registry ATTRA"},
                            "refd-itemidlist": {"itemid": {
                                "$": "76649091242",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "27"},
                                "pagerange": {
                                    "@first": "958",
                                    "@last": "963"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Pavelka",
                                    "ce:indexed-name": "Pavelka K."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Forejtova",
                                    "ce:indexed-name": "Forejtova S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Stolfa",
                                    "ce:indexed-name": "Stolfa J."
                                }
                            ]},
                            "ref-sourcetitle": "Clin Exp Rheumatol"
                        }
                    },
                    {
                        "ref-fulltext": "Scire CA Caporali R Sarzi-Puttini P. Drug survival of the first course of anti-TNF agents in patients with rheumatoid arthritis and seronegative spondyloarthritis: analysis from the MonitorNet database. Clin Exp Rheumatol. 2013; 31: 857-863.",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Drug survival of the first course of anti-TNF agents in patients with rheumatoid arthritis and seronegative spondyloarthritis: Analysis from the MonitorNet database"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84892460666",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "31"},
                                "pagerange": {
                                    "@first": "857",
                                    "@last": "863"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Scire",
                                    "ce:indexed-name": "Scire C.A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Caporali",
                                    "ce:indexed-name": "Caporali R."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Sarzi-Puttini",
                                    "ce:indexed-name": "Sarzi-Puttini P."
                                }
                            ]},
                            "ref-sourcetitle": "Clin Exp Rheumatol"
                        }
                    },
                    {
                        "ref-fulltext": "Fafa BP Louzada-Junior P Titton DC. Drug survival and causes of discontinuation of the first anti-TNF in ankylosing spondylitis compared with rheumatoid arthritis: analysis from BIOBADABRASIL. Clin Rheumatol. 2015; 34: 921-927.",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Drug survival and causes of discontinuation of the first anti-TNF in ankylosing spondylitis compared with rheumatoid arthritis: Analysis from BIOBADABRASIL"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84937758454",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "34"},
                                "pagerange": {
                                    "@first": "921",
                                    "@last": "927"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Fafa",
                                    "ce:indexed-name": "Fafa B."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Louzada-Junior",
                                    "ce:indexed-name": "Louzada-Junior P."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "D.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Titton",
                                    "ce:indexed-name": "Titton D.C."
                                }
                            ]},
                            "ref-sourcetitle": "Clin Rheumatol"
                        }
                    },
                    {
                        "ref-fulltext": "Heinonen AV Aaltonen KJ Joensuu JT. Effectiveness and drug survival of TNF inhibitors in the treatment of ankylosing spondylitis: a prospective cohort study. J Rheumatol. 2015; 42: 2339-2346.",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Effectiveness and drug survival of TNF inhibitors in the treatment of ankylosing spondylitis: A prospective cohort study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84948742746",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "42"},
                                "pagerange": {
                                    "@first": "2339",
                                    "@last": "2346"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.V.",
                                    "@_fa": "true",
                                    "ce:surname": "Heinonen",
                                    "ce:indexed-name": "Heinonen A.V."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "K.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Aaltonen",
                                    "ce:indexed-name": "Aaltonen K.J."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "J.T.",
                                    "@_fa": "true",
                                    "ce:surname": "Joensuu",
                                    "ce:indexed-name": "Joensuu J.T."
                                }
                            ]},
                            "ref-sourcetitle": "J Rheumatol"
                        }
                    },
                    {
                        "ref-fulltext": "Wallman JK Kapetanovic MC Petersson IF. Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients-baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice. Arthritis Res Ther. 2015; 17: 378.",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients - Baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84951847479",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "17"},
                                "pagerange": {"@first": "378"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J.K.",
                                    "@_fa": "true",
                                    "ce:surname": "Wallman",
                                    "ce:indexed-name": "Wallman J.K."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Kapetanovic",
                                    "ce:indexed-name": "Kapetanovic M.C."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "I.F.",
                                    "@_fa": "true",
                                    "ce:surname": "Petersson",
                                    "ce:indexed-name": "Petersson I.F."
                                }
                            ]},
                            "ref-sourcetitle": "Arthritis Res Ther"
                        }
                    },
                    {
                        "ref-fulltext": "Glintborg B SÃ¸rensen IJ Ostergaard M. Ankylosing spondylitis versus nonradiographic axial spondyloarthritis: comparison of tumor necrosis factor inhibitor effectiveness and effect of HLA-B27 status. An observational cohort study from the nationwide DANBIO registry. J Rheumatol. 2017; 44: 59-69.",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Ankylosing spondylitis versus nonradiographic axial spondyloarthritis: Comparison of tumor necrosis factor inhibitor effectiveness and effect of HLA-B27 status. An observational cohort study from the nationwide DANBIO registry"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85008145734",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "44"},
                                "pagerange": {
                                    "@first": "59",
                                    "@last": "69"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "B.",
                                    "@_fa": "true",
                                    "ce:surname": "Glintborg",
                                    "ce:indexed-name": "Glintborg B."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "I.J.",
                                    "@_fa": "true",
                                    "ce:surname": "SÃ¸rensen",
                                    "ce:indexed-name": "Sorensen I.J."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Ostergaard",
                                    "ce:indexed-name": "Ostergaard M."
                                }
                            ]},
                            "ref-sourcetitle": "J Rheumatol"
                        }
                    },
                    {
                        "ref-fulltext": "Carmona L GÃ³mez-Reino JJ. BIOBADASER Group. Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER. Arthritis Res Ther. 2006; 8: R72.",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER"},
                            "refd-itemidlist": {"itemid": {
                                "$": "34147219117",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {"@first": "R72"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Carmona",
                                        "ce:indexed-name": "Carmona L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J.J.",
                                        "@_fa": "true",
                                        "ce:surname": "GÃ³mez-Reino",
                                        "ce:indexed-name": "Gomez-Reino J.J."
                                    }
                                ],
                                "collaboration": {
                                    "@seq": "1",
                                    "ce:text": "BIOBADASER Group",
                                    "ce:indexed-name": "BIOBADASER Group"
                                }
                            },
                            "ref-sourcetitle": "Arthritis Res Ther"
                        }
                    },
                    {
                        "ref-fulltext": "Mok CC Chan KY Lee KL. Factors associated with withdrawal of the anti-TNF biologics in the treatment of rheumatic diseases: data from the Hong Kong Biologics Registry. Int J Rheum Dis. 2014; 17 (Suppl 3): 1-8.",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Factors associated with withdrawal of the anti-TNF biologics in the treatment of rheumatic diseases: Data from the Hong Kong Biologics Registry"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84921292134",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "17"},
                                "pagerange": {
                                    "@first": "1",
                                    "@last": "8"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C.C.",
                                    "@_fa": "true",
                                    "ce:surname": "Mok",
                                    "ce:indexed-name": "Mok C.C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "K.Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Chan",
                                    "ce:indexed-name": "Chan K.Y."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K.L.",
                                    "@_fa": "true",
                                    "ce:surname": "Lee",
                                    "ce:indexed-name": "Lee K.L."
                                }
                            ]},
                            "ref-sourcetitle": "Int J Rheum Dis"
                        }
                    },
                    {
                        "ref-fulltext": "Palazzi C D'Angelo S Gilio M. Pharmacological therapy of spondyloarthritis. Expert Opin Pharmacother. 2015; 16: 1495-1504.",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Pharmacological therapy of spondyloarthritis"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84933532205",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {
                                    "@first": "1495",
                                    "@last": "1504"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Palazzi",
                                    "ce:indexed-name": "Palazzi C."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "D'Angelo",
                                    "ce:indexed-name": "D'Angelo S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Gilio",
                                    "ce:indexed-name": "Gilio M."
                                }
                            ]},
                            "ref-sourcetitle": "Expert Opin Pharmacother"
                        }
                    },
                    {
                        "ref-fulltext": "Arends S Brouwer E van der Veer E. Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study. Arthritis Res Ther. 2011; 13: R94.",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: A prospective longitudinal observational cohort study"},
                            "refd-itemidlist": {"itemid": {
                                "$": "79959260432",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {"@first": "R94"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Arends",
                                    "ce:indexed-name": "Arends S."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Brouwer",
                                    "ce:indexed-name": "Brouwer E."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Van Der Veer",
                                    "ce:indexed-name": "Van Der Veer E."
                                }
                            ]},
                            "ref-sourcetitle": "Arthritis Res Ther"
                        }
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60199575",
            "affilname": "Siriraj Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hatyai",
            "@id": "60025527",
            "affilname": "Faculty of Medicine, Prince of Songkia University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025527",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60005255",
            "affilname": "Rajavithi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005255",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Chaing Mai",
            "@id": "60000881",
            "affilname": "Chiang Mai University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": null,
            "@id": "118691477",
            "affilname": "Phramongkutklao Hospital and College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/118691477",
            "affiliation-country": "Thailand"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85058911924",
        "dc:description": "Objective This study aimed to evaluate the long-term effectiveness and safety of the first anti-tumor necrosis factor therapy (TNFi) and to identify the associated factors of drug discontinuation in patients with spondyloarthritis. Methods This was a medical records review study. Patients with spondyloarthritis who were prescribed the first TNFi between December 2009 and October 2014 in the Rheumatic Disease Prior Authorization registry were enrolled. Baseline clinical data were retrieved. The Cox proportional hazards model was used to identify factors associated with discontinuation of drugs. Results Among 138 patients, 97 had ankylosing spondylitis (AS), and 41 had psoriatic arthritis (PsA). The effectiveness of TNFi in AS and PsA was 55% to 59% at 4 months and 75% to 96% at 3 years, as measured by a 50% decrease in the Bath Ankylosing Spondylitis Disease Activity Index from baseline. For PsA with peripheral arthritis, improvement of the joint count by 50% was observed in 61.8% of patients at 4 months and 100% at 3 years. Survival from TNFi was 63% for AS and 56% for PsA at 3 years. For AS, the factors associated with good response leading to discontinuation of TNFi were baseline patient global assessment 3 to 6/10 (hazard ratio [HR], 6.3) and the use of leflunomide (HR, 6.0) and infliximab (HR, 4.8). A good response (38.5%) was the most common cause of discontinuation of the first TNFi, followed by toxicity (28.2%), nonadherence (20.5%), and lack of effectiveness (12.8%). Conclusions Ankylosing spondylitis and PsA responded well to TNFi during the 3-year follow-up. The retention rate was approximately 60% for AS and PsA. A good response to the first TNFi was the most common reason for discontinuation.",
        "pubmed-id": "29517554",
        "prism:coverDate": "2019-01-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85058911924",
        "dc:creator": {"author": [{
            "ce:given-name": "Praveena",
            "preferred-name": {
                "ce:given-name": "Praveena",
                "ce:initials": "P.",
                "ce:surname": "Chiowchanwisawakit",
                "ce:indexed-name": "Chiowchanwisawakit P."
            },
            "@seq": "1",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60199575",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575"
            },
            "ce:degrees": "MD",
            "ce:surname": "Chiowchanwisawakit",
            "@auid": "12645013800",
            "author-url": "https://api.elsevier.com/content/author/author_id/12645013800",
            "ce:indexed-name": "Chiowchanwisawakit P."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85058911924"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85058911924&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85058911924&origin=inward"
            }
        ],
        "source-id": "19236",
        "citedby-count": "3",
        "prism:volume": "25",
        "subtype": "ar",
        "dc:title": "Effectiveness and Drug Survival of Anti-Tumor Necrosis Factor Therapies in Patients with Spondyloarthritis: Analysis from the Thai Rheumatic Disease Prior Authorization Registry",
        "openaccess": "0",
        "prism:issn": "15367355 10761608",
        "publishercopyright": "Â© 2018 Wolters Kluwer Health, Inc. All rights reserved.",
        "prism:issueIdentifier": "1",
        "subtypeDescription": "Article",
        "prism:publicationName": "Journal of Clinical Rheumatology",
        "prism:pageRange": "9-15",
        "prism:endingPage": "15",
        "openaccessFlag": "false",
        "prism:doi": "10.1097/RHU.0000000000000741",
        "prism:startingPage": "9",
        "dc:identifier": "SCOPUS_ID:85058911924",
        "dc:publisher": "Lippincott Williams and Wilkinskathiest.clai@apta.org"
    },
    "idxterms": {"mainterm": [
        {
            "$": "Adult",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Antirheumatic Agents",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Drug Administration Schedule",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Etanercept",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Female",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Humans",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Infliximab",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Male",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Middle Aged",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Proportional Hazards Models",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Registries",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Retrospective Studies",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Spondylarthritis",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Thailand",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Treatment Outcome",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Tumor Necrosis Factor-alpha",
            "@weight": "b",
            "@candidate": "n"
        },
        {
            "$": "Withholding Treatment",
            "@weight": "a",
            "@candidate": "n"
        }
    ]},
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "anti-TNF agent"
        },
        {
            "@_fa": "true",
            "$": "AS"
        },
        {
            "@_fa": "true",
            "$": "PsA"
        },
        {
            "@_fa": "true",
            "$": "spondyloarthritis"
        },
        {
            "@_fa": "true",
            "$": "survival"
        }
    ]},
    "subject-areas": {"subject-area": [{
        "@_fa": "true",
        "$": "Rheumatology",
        "@code": "2745",
        "@abbrev": "MEDI"
    }]},
    "authors": {"author": [
        {
            "ce:given-name": "Praveena",
            "preferred-name": {
                "ce:given-name": "Praveena",
                "ce:initials": "P.",
                "ce:surname": "Chiowchanwisawakit",
                "ce:indexed-name": "Chiowchanwisawakit P."
            },
            "@seq": "1",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60199575",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575"
            },
            "ce:degrees": "MD",
            "ce:surname": "Chiowchanwisawakit",
            "@auid": "12645013800",
            "author-url": "https://api.elsevier.com/content/author/author_id/12645013800",
            "ce:indexed-name": "Chiowchanwisawakit P."
        },
        {
            "ce:given-name": "Wanruchada",
            "preferred-name": {
                "ce:given-name": "Wanruchada",
                "ce:initials": "W.",
                "ce:surname": "Katchamart",
                "ce:indexed-name": "Katchamart W."
            },
            "@seq": "2",
            "ce:initials": "W.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60199575",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199575"
            },
            "ce:degrees": "MD",
            "ce:surname": "Katchamart",
            "@auid": "26654177400",
            "author-url": "https://api.elsevier.com/content/author/author_id/26654177400",
            "ce:indexed-name": "Katchamart W."
        },
        {
            "ce:given-name": "Manathip",
            "preferred-name": {
                "ce:given-name": "Manathip",
                "ce:initials": "M.",
                "ce:surname": "Osiri",
                "ce:indexed-name": "Osiri M."
            },
            "@seq": "3",
            "ce:initials": "M.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:degrees": "MD, MSc",
            "ce:surname": "Osiri",
            "@auid": "6701738522",
            "author-url": "https://api.elsevier.com/content/author/author_id/6701738522",
            "ce:indexed-name": "Osiri M."
        },
        {
            "ce:given-name": "Pongthorn",
            "preferred-name": {
                "ce:given-name": "Pongthorn",
                "ce:initials": "P.",
                "ce:surname": "Narongroeknawin",
                "ce:indexed-name": "Narongroeknawin P."
            },
            "@seq": "4",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "118691477",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/118691477"
            },
            "ce:degrees": "MD",
            "ce:surname": "Narongroeknawin",
            "@auid": "35099091000",
            "author-url": "https://api.elsevier.com/content/author/author_id/35099091000",
            "ce:indexed-name": "Narongroeknawin P."
        },
        {
            "ce:given-name": "Parawee",
            "preferred-name": {
                "ce:given-name": "Parawee",
                "ce:initials": "P.",
                "ce:surname": "Chevaisrakul",
                "ce:indexed-name": "Chevaisrakul P."
            },
            "@seq": "5",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60199578",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578"
            },
            "ce:degrees": "MD",
            "ce:surname": "Chevaisrakul",
            "@auid": "57191876780",
            "author-url": "https://api.elsevier.com/content/author/author_id/57191876780",
            "ce:indexed-name": "Chevaisrakul P."
        },
        {
            "ce:given-name": "Tasanee",
            "preferred-name": {
                "ce:given-name": "Tasanee",
                "ce:initials": "T.",
                "ce:surname": "Kitumnuaypong",
                "ce:indexed-name": "Kitumnuaypong T."
            },
            "@seq": "6",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60005255",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005255"
            },
            "ce:degrees": "MD",
            "ce:surname": "Kitumnuaypong",
            "@auid": "7801652692",
            "author-url": "https://api.elsevier.com/content/author/author_id/7801652692",
            "ce:indexed-name": "Kitumnuaypong T."
        },
        {
            "ce:given-name": "Boonjing",
            "preferred-name": {
                "ce:given-name": "Boonjing",
                "ce:initials": "B.",
                "ce:surname": "Siripaitoon",
                "ce:indexed-name": "Siripaitoon B."
            },
            "@seq": "7",
            "ce:initials": "B.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60025527",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60025527"
            },
            "ce:degrees": "MD",
            "ce:surname": "Siripaitoon",
            "@auid": "6506081502",
            "author-url": "https://api.elsevier.com/content/author/author_id/6506081502",
            "ce:indexed-name": "Siripaitoon B."
        },
        {
            "ce:given-name": "Worawit",
            "preferred-name": {
                "ce:given-name": "Worawit",
                "ce:initials": "W.",
                "ce:surname": "Louthrenoo",
                "ce:indexed-name": "Louthrenoo W."
            },
            "@seq": "8",
            "ce:initials": "W.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60000881",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60000881"
            },
            "ce:degrees": "MD",
            "ce:surname": "Louthrenoo",
            "@auid": "7004628644",
            "author-url": "https://api.elsevier.com/content/author/author_id/7004628644",
            "ce:indexed-name": "Louthrenoo W."
        }
    ]}
}}